Prolia, Injektionslösung in Fertigspritze mit Nadelschutz

7680602100013 CH-60210 Injektionslösung in Fertigspritze mit Nadelschutz
Prolia, Injektionslösung in Fertigspritze mit Nadelschutz
Prolia, Injektionslösung in Fertigspritze mit Nadelschutz
Prolia, Injektionslösung in Fertigspritze mit Nadelschutz
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Spritze(n)
Galenic form
Injektionslösung in Fertigspritze mit Nadelschutz
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
30/06/2025
Patient information leaflet
Français
30/06/2025
Patient information leaflet
Italien
30/06/2025
Summary of Product Characteristics
Allemand
30/06/2025
Summary of Product Characteristics
Français
30/06/2025
Summary of Product Characteristics
Italien
30/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
60.0 MG Substance Wirkstoff (Principe actif)
(N/A)
47.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.4 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 287.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2010

Authorization holder

Amgen Switzerland AG

6343 Risch

Authorization information

Swissmedic authorization number
60210
Drug name
Prolia, Injektionslösung in Fertigspritze mit Nadelschutz
Galenic form
LSPA
ATC Code
M05BX04
Authorization status
Z
Dispensing category
B
First authorization
03/08/2010
Authorization expiration date
31/12/9999
IT Number
07.99.0.
Domain
Human medicine
Field of application
Osteoporose

Package details

Description (FR)
PROLIA 60 mg/ml protect aiguille ser pré
Description (DE)
PROLIA 60 mg/ml m Nadelschutz Fertspr
Market launch
03/08/2010
Narcotic (BTM)
No